Correlation Between Sunshine Biopharma and Ubiquitech Software

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Ubiquitech Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Ubiquitech Software into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma Warrant and Ubiquitech Software, you can compare the effects of market volatilities on Sunshine Biopharma and Ubiquitech Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Ubiquitech Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Ubiquitech Software.

Diversification Opportunities for Sunshine Biopharma and Ubiquitech Software

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Sunshine and Ubiquitech is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma Warrant and Ubiquitech Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ubiquitech Software and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma Warrant are associated (or correlated) with Ubiquitech Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ubiquitech Software has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Ubiquitech Software go up and down completely randomly.

Pair Corralation between Sunshine Biopharma and Ubiquitech Software

Assuming the 90 days horizon Sunshine Biopharma is expected to generate 11.01 times less return on investment than Ubiquitech Software. But when comparing it to its historical volatility, Sunshine Biopharma Warrant is 12.97 times less risky than Ubiquitech Software. It trades about 0.32 of its potential returns per unit of risk. Ubiquitech Software is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Ubiquitech Software on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Ubiquitech Software or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy90.91%
ValuesDaily Returns

Sunshine Biopharma Warrant  vs.  Ubiquitech Software

 Performance 
       Timeline  
Sunshine Biopharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Ubiquitech Software 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Ubiquitech Software are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Ubiquitech Software unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sunshine Biopharma and Ubiquitech Software Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sunshine Biopharma and Ubiquitech Software

The main advantage of trading using opposite Sunshine Biopharma and Ubiquitech Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Ubiquitech Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ubiquitech Software will offset losses from the drop in Ubiquitech Software's long position.
The idea behind Sunshine Biopharma Warrant and Ubiquitech Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges